Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis

References

• Freeman WD, Aguilar MI. Prevention of cardioembolic stroke. Neurotherapeutics. 2011;8(3):488–502.
   PubMed Web of Science ®Google Scholar
• García-Berrocoso T, Fernández-Cadenas I, Delgado P, et al. Blood biomarkers in cardioembolic stroke. Current Cardiol Rev. 2010;6(3):194–201.
   PubMedGoogle Scholar
• Amarenco P, Bogousslavsky J, Caplan L, et al. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27(5):493–501.
   PubMed Web of Science ®Google Scholar
• Yang H-L, Lin Y-P, Long Y, et al. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2014;23(7):1882–1889.
   PubMed Web of Science ®Google Scholar
• Llombart V, Antolin-Fontes A, Bustamante A, et al. B-type natriuretic peptides help in cardioembolic stroke diagnosis pooled data meta-analysis. Stroke. 2015;46(5):1187–1195.
   PubMed Web of Science ®Google Scholar
• Kara K, Lehmann N, Neumann T, et al. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study. Int J Cardiol. 2015;183:155–161.
   PubMed Web of Science ®Google Scholar
• Oremus M, Don-Wauchope A, McKelvie R, et al. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev. 2014;19(4):471–505.
   PubMed Web of Science ®Google Scholar
• Buchner S, Jungbauer C, Birner C, et al. Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide. Biomark Med. 2009;3(5):465–481.
   PubMed Web of Science ®Google Scholar
• Biteker M, Özden T, Dayan A, et al. Aortic stiffness and plasma brain natriuretic peptide predicts mortality in acute ischemic stroke. Int J Stroke. 2015;10(5):679–685.
   PubMed Web of Science ®Google Scholar
• Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008;39(8):2280–2287.
   PubMed Web of Science ®Google Scholar
• Naya T, Yukiiri K, Hosomi N, et al. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation. Cerebrovasc Dis. 2008;26(4):434–440.
   PubMed Web of Science ®Google Scholar
• Okazaki T, Yamamoto Y, Yoda K, et al. The ratio of D-dimer to brain natriuretic peptide may help to differentiate between cerebral infarction with and without acute aortic dissection. J Neurol Sci. 2014;340(1):133–138.
   PubMed Web of Science ®Google Scholar
• Sakai K, Shibazaki K, Kimura K, et al. Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke patients: brain natriuretic peptide stroke prospective study. Eur Neurol. 2013;69(4):246–251.
   PubMed Web of Science ®Google Scholar
• Santamarina E, Penalba A, García-Berrocoso T, et al. Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol. 2012;259(12):2538–2545.
   PubMed Web of Science ®Google Scholar
• Shibazaki K, Kimura K, Iguchi Y, et al. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Internal Med (Tokyo, Japan). 2008;48(5):259–264.
   Web of Science ®Google Scholar
• Tamura H, Watanabe T, Nishiyama S, et al. Elevated plasma brain natriuretic peptide levels predict left atrial appendage dysfunction in patients with acute ischemic stroke. J Cardiol. 2012;60(2):126–132.
   PubMed Web of Science ®Google Scholar
• Yukiiri K, Hosomi N, Naya T, et al. Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke. BMC Neurol. 2008;8(1):45–46.
   PubMed Web of Science ®Google Scholar
• Zhixin W, Lianhong Y, Wei H, et al. The value of the use of plasma B-type natriuretic peptide among acute ischemic stroke patients in a Chinese emergency department. Clin Neurol Neurosur. 2013;115(9):1671–1676.
   PubMed Web of Science ®Google Scholar
• Fonseca AC, Matias JS, Pinho e Melo T, et al. N‐terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke. Int J Stroke. 2011;6(5):398–403.
   PubMed Web of Science ®Google Scholar
• Fonseca A, Matias J, Pires C, et al. Time course of NT-proBNP levels after acute ischemic stroke. Acta Neurologica Scandinavica. 2013;128(4):235–240.
   PubMed Web of Science ®Google Scholar
• Hajsadeghi S, Kashani Amin L, Bakhshandeh H, et al. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(4):554–560.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Yáñez M, Sobrino T, Blanco M, et al. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke. Dis Markers. 2009;26(4):189–195.
   PubMed Web of Science ®Google Scholar
• Roldán V, Vílchez JA, Manzano-Fernández S, et al. Usefulness of N-terminal pro–B-type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke. 2014;45(3):696–701.
   PubMed Web of Science ®Google Scholar
• Zecca B, Mandelli C, Maino A, et al. A bioclinical pattern for the early diagnosis of cardioembolic stroke. Emerg Med Int. 2014;2014:132–141.
   Google Scholar
• Sergeeva IA, Christoffels VM. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis. 2013;1832(12):2403–2413.
   PubMed Web of Science ®Google Scholar
• Battistoni A, Rubattu S, Volpe M. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol. 2012;157(2):160–168.
   PubMed Web of Science ®Google Scholar
• Llombart V, Garcia-Berrocoso T, Bustamante A, et al. Cardioembolic stroke diagnosis using blood biomarkers. Current Cardiol Rev. 2013;9(4):340–352.
   PubMedGoogle Scholar
• Kimura K, Yamaguchi Y, Horii M, et al. ANP is cleared much faster than BNP in patients with congestive heart failure. Eur J Clin Pharmacol. 2007;63(7):699–702.
   PubMed Web of Science ®Google Scholar
• Çıkanlar NÖ. Can B-type natriuretic peptide (BNP) be A predictor biomarker of stroke mortality? Neurology. 2013;81(23):1976–1985.
   PubMed Web of Science ®Google Scholar
• Eindhoven JA, van den Bosch AE, Jansen PR, et al. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J Am Coll Cardiol. 2012;60(21):2140–2149.
   PubMed Web of Science ®Google Scholar
• García-Berrocoso T, Giralt D, Bustamante A, et al. B-type natriuretic peptides and mortality after stroke A systematic review and meta-analysis. Neurology. 2013;81(23):1976–1985.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357–2368.
   PubMed Web of Science ®Google Scholar
• Iltumur K, Karabulut A, Apak I, et al. Elevated plasma N-terminal pro–brain natriuretic peptide levels in acute ischemic stroke. Am Heart J. 2006;151(5):1115–1122.
   PubMed Web of Science ®Google Scholar
• Jensen JK, Mickley H, Bak S, et al. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis. 2006;22(5-6):439–444.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Yamaguchi T, Seida M, et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis. 2005;19(3):157–164.
   PubMed Web of Science ®Google Scholar
• Gegenhuber A, Mueller T, Firlinger F, et al. Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure. Clin Chem. 2004;50(2):454–456.
   PubMed Web of Science ®Google Scholar